Paragraph IV Certifications: How Generic Drug Makers Challenge Patents Before Launch
Paragraph IV certifications let generic drug makers challenge brand-name patents before launch, speeding up access to cheaper medicines. This legal tool under the Hatch-Waxman Act has saved U.S. consumers over $2 trillion since 1984.
Read more